EXPERIENCE OF THE ADALIMUMAB APPLICATION FOR THE PATIENT WITH EARLY DEBUT OF JUVENILE IDIOPATHIC ARTHRITIS AND UVEITIS

The case of early debut and heavy course of juvenile idiopathic arthritis in the patient at the age of 1 year and 8 months, associated with uveitis refractory to the therapy by methotrexate and nonsteroid antiinflammatory preparations is presented. The given clinical example shows high therapeutic e...

Full description

Saved in:
Bibliographic Details
Main Authors: K. B. Isaeva, E. I. Alexeeva, R. V. Denisova, T. V. Sleptsova, Т. М. Bzarova, S. I. Valieva, E. V. Mitenko, E. G. Chistyakova, А. М. Chomakhidze
Format: Article
Language:English
Published: "Paediatrician" Publishers LLC 2014-07-01
Series:Вопросы современной педиатрии
Subjects:
Online Access:https://vsp.spr-journal.ru/jour/article/view/185
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849410061047169024
author K. B. Isaeva
E. I. Alexeeva
R. V. Denisova
T. V. Sleptsova
Т. М. Bzarova
S. I. Valieva
E. V. Mitenko
E. G. Chistyakova
А. М. Chomakhidze
author_facet K. B. Isaeva
E. I. Alexeeva
R. V. Denisova
T. V. Sleptsova
Т. М. Bzarova
S. I. Valieva
E. V. Mitenko
E. G. Chistyakova
А. М. Chomakhidze
author_sort K. B. Isaeva
collection DOAJ
description The case of early debut and heavy course of juvenile idiopathic arthritis in the patient at the age of 1 year and 8 months, associated with uveitis refractory to the therapy by methotrexate and nonsteroid antiinflammatory preparations is presented. The given clinical example shows high therapeutic efficiency of the adalimumab. To the 8th week of treatment inflammatory changes in conjunctiva were stopped, to the 12th week the stage of inactive illness was registered, i.e. the patient had no inflammatory changes in joints, uveitis activity signs, increase of laboratory indicators of illness activity. Duration of remission of articulate syndrome and uveitis made 9 months.
format Article
id doaj-art-0c94d7663ca6468cb8ac9e38e5faf23a
institution Kabale University
issn 1682-5527
1682-5535
language English
publishDate 2014-07-01
publisher "Paediatrician" Publishers LLC
record_format Article
series Вопросы современной педиатрии
spelling doaj-art-0c94d7663ca6468cb8ac9e38e5faf23a2025-08-20T03:35:16Zeng"Paediatrician" Publishers LLCВопросы современной педиатрии1682-55271682-55352014-07-0113415616110.15690/vsp.v13i4.1102185EXPERIENCE OF THE ADALIMUMAB APPLICATION FOR THE PATIENT WITH EARLY DEBUT OF JUVENILE IDIOPATHIC ARTHRITIS AND UVEITISK. B. Isaeva0E. I. Alexeeva1R. V. Denisova2T. V. Sleptsova3Т. М. Bzarova4S. I. Valieva5E. V. Mitenko6E. G. Chistyakova7А. М. Chomakhidze8Scientific Centre of Children Health, MoscowScientific Centre of Children Health, Moscow; I.M. Sechenov First Moscow State Medical UniversityScientific Centre of Children Health, MoscowScientific Centre of Children Health, MoscowScientific Centre of Children Health, MoscowScientific Centre of Children Health, MoscowScientific Centre of Children Health, MoscowScientific Centre of Children Health, Moscow; I.M. Sechenov First Moscow State Medical UniversityScientific Centre of Children Health, MoscowThe case of early debut and heavy course of juvenile idiopathic arthritis in the patient at the age of 1 year and 8 months, associated with uveitis refractory to the therapy by methotrexate and nonsteroid antiinflammatory preparations is presented. The given clinical example shows high therapeutic efficiency of the adalimumab. To the 8th week of treatment inflammatory changes in conjunctiva were stopped, to the 12th week the stage of inactive illness was registered, i.e. the patient had no inflammatory changes in joints, uveitis activity signs, increase of laboratory indicators of illness activity. Duration of remission of articulate syndrome and uveitis made 9 months.https://vsp.spr-journal.ru/jour/article/view/185childrenjuvenile idiopathic arthritisuveitisadalimumabtreatment
spellingShingle K. B. Isaeva
E. I. Alexeeva
R. V. Denisova
T. V. Sleptsova
Т. М. Bzarova
S. I. Valieva
E. V. Mitenko
E. G. Chistyakova
А. М. Chomakhidze
EXPERIENCE OF THE ADALIMUMAB APPLICATION FOR THE PATIENT WITH EARLY DEBUT OF JUVENILE IDIOPATHIC ARTHRITIS AND UVEITIS
Вопросы современной педиатрии
children
juvenile idiopathic arthritis
uveitis
adalimumab
treatment
title EXPERIENCE OF THE ADALIMUMAB APPLICATION FOR THE PATIENT WITH EARLY DEBUT OF JUVENILE IDIOPATHIC ARTHRITIS AND UVEITIS
title_full EXPERIENCE OF THE ADALIMUMAB APPLICATION FOR THE PATIENT WITH EARLY DEBUT OF JUVENILE IDIOPATHIC ARTHRITIS AND UVEITIS
title_fullStr EXPERIENCE OF THE ADALIMUMAB APPLICATION FOR THE PATIENT WITH EARLY DEBUT OF JUVENILE IDIOPATHIC ARTHRITIS AND UVEITIS
title_full_unstemmed EXPERIENCE OF THE ADALIMUMAB APPLICATION FOR THE PATIENT WITH EARLY DEBUT OF JUVENILE IDIOPATHIC ARTHRITIS AND UVEITIS
title_short EXPERIENCE OF THE ADALIMUMAB APPLICATION FOR THE PATIENT WITH EARLY DEBUT OF JUVENILE IDIOPATHIC ARTHRITIS AND UVEITIS
title_sort experience of the adalimumab application for the patient with early debut of juvenile idiopathic arthritis and uveitis
topic children
juvenile idiopathic arthritis
uveitis
adalimumab
treatment
url https://vsp.spr-journal.ru/jour/article/view/185
work_keys_str_mv AT kbisaeva experienceoftheadalimumabapplicationforthepatientwithearlydebutofjuvenileidiopathicarthritisanduveitis
AT eialexeeva experienceoftheadalimumabapplicationforthepatientwithearlydebutofjuvenileidiopathicarthritisanduveitis
AT rvdenisova experienceoftheadalimumabapplicationforthepatientwithearlydebutofjuvenileidiopathicarthritisanduveitis
AT tvsleptsova experienceoftheadalimumabapplicationforthepatientwithearlydebutofjuvenileidiopathicarthritisanduveitis
AT tmbzarova experienceoftheadalimumabapplicationforthepatientwithearlydebutofjuvenileidiopathicarthritisanduveitis
AT sivalieva experienceoftheadalimumabapplicationforthepatientwithearlydebutofjuvenileidiopathicarthritisanduveitis
AT evmitenko experienceoftheadalimumabapplicationforthepatientwithearlydebutofjuvenileidiopathicarthritisanduveitis
AT egchistyakova experienceoftheadalimumabapplicationforthepatientwithearlydebutofjuvenileidiopathicarthritisanduveitis
AT amchomakhidze experienceoftheadalimumabapplicationforthepatientwithearlydebutofjuvenileidiopathicarthritisanduveitis